Scientific Session
.png "Peter Merkel, MD, MPH photo")
Peter Merkel, MD, MPH
University of Pennsylvania
Philadelphia, PA, United States
Disclosure: Disclosure(s): AbbVie: Consultant (Ongoing), Grant/Research Support (Ongoing); AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing); Boeringher-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); ChemoCentryx: Consultant (Ongoing), Grant/Research Support (Ongoing); CSL Behring: Consultant (Ongoing); Dynacure: Consultant (Ongoing); Eicos: Grant/Research Support (Ongoing); Electra: Grant/Research Support (Ongoing); EMDSerono: Consultant (Terminated, December 31, 2021); Forbius: Consultant (Terminated, December 31, 2021), Grant/Research Support (Terminated, December 31, 2021); Genentech/Roche: Consultant (Terminated, December 31, 2021), Grant/Research Support (Terminated, December 31, 2021); Genzyme/Sanofi: Consultant (Terminated, December 31, 2021), Grant/Research Support (Terminated, December 31, 2021); GlaxoSmithKline: Consultant (Ongoing), Grant/Research Support (Ongoing); Immagene: Consultant (Ongoing); InflaRx: Consultant (Ongoing), Grant/Research Support (Ongoing); Jannsen: Consultant (Ongoing); Kiniksa: Consultant (Terminated, July 31, 2020); Kyverna: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Magenta: Consultant (Ongoing); Neutrolis: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing); Pfizer: Consultant (Ongoing); Q32: Consultant (Ongoing); Regeneron: Consultant (Ongoing); Sparrow: Consultant (Ongoing); Takeda: Consultant (Ongoing), Grant/Research Support (Ongoing); UpToDate: Royalties (Ongoing)
